HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 232 filers reported holding HERBALIFE LTD in Q1 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,784 | -12.8% | 199 | -17.4% | 0.00% | – |
| Q2 2023 | $3,191 | -82.8% | 241 | -79.0% | 0.00% | – |
| Q1 2023 | $18,515 | +8.7% | 1,150 | +0.4% | 0.00% | – |
| Q4 2022 | $17,038 | -25.9% | 1,145 | 0.0% | 0.00% | – |
| Q3 2022 | $23,000 | 0.0% | 1,145 | 0.0% | 0.00% | – |
| Q2 2022 | $23,000 | -48.9% | 1,145 | -21.9% | 0.00% | – |
| Q1 2022 | $45,000 | +66.7% | 1,466 | +125.2% | 0.00% | – |
| Q4 2021 | $27,000 | +575.0% | 651 | +592.6% | 0.00% | – |
| Q3 2021 | $4,000 | – | 94 | +2250.0% | 0.00% | – |
| Q4 2019 | $0 | – | 4 | -50.0% | 0.00% | – |
| Q3 2019 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 8 | -72.4% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 29 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 29 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | – | 29 | +625.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 4 | -81.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 21 | +10.5% | 0.00% | – |
| Q3 2013 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |